SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-037614
Filing Date
2024-03-28
Accepted
2024-03-28 07:30:39
Documents
86
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K grtx-20231231.htm   iXBRL 10-K 2440417
2 EX-3.2 grtx-ex3_2.htm EX-3.2 266419
3 EX-23.1 grtx-ex23_1.htm EX-23.1 2228
4 EX-31.1 grtx-ex31_1.htm EX-31.1 11891
5 EX-31.2 grtx-ex31_2.htm EX-31.2 11864
6 EX-32.1 grtx-ex32_1.htm EX-32.1 7542
7 EX-32.2 grtx-ex32_2.htm EX-32.2 7512
8 EX-97.1 grtx-ex97_1.htm EX-97.1 40023
  Complete submission text file 0000950170-24-037614.txt   9512951

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT grtx-20231231.xsd EX-101.SCH 1542157
90 EXTRACTED XBRL INSTANCE DOCUMENT grtx-20231231_htm.xml XML 1252812
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39114 | Film No.: 24793513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)